Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Westaby, D. Fenor de La Maza, M.D. Paschalis, A. Jimenez-Vacas, J.M. Welti, J. de Bono, J. Sharp, A. (2022). A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer. Annual review of pharmacology and toxicology, Vol.62 (1), pp. 131-153.  show abstract

Sheehan, B. Neeb, A. Buroni, L. Paschalis, A. Riisnaes, R. Gurel, B. Gil, V. Miranda, S. Crespo, M. Guo, C. Jiménez Vacas, J. Figueiredo, I. Ferreira, A. Welti, J. Yuan, W. Carreira, S. Sharp, A. de Bono, J. (2022). Prostate Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. , Vol.28 (14), pp. 3104-3115.  show abstract

Sowalsky, A.G. Figueiredo, I. Lis, R.T. Coleman, I. Gurel, B. Bogdan, D. Yuan, W. Russo, J.W. Bright, J.R. Whitlock, N.C. Trostel, S.Y. Ku, A.T. Patel, R.A. True, L.D. Welti, J. Jimenez-Vacas, J.M. Rodrigues, D.N. Riisnaes, R. Neeb, A. Sprenger, C.T. Swain, A. Wilkinson, S. Karzai, F. Dahut, W.L. Balk, S.P. Corey, E. Nelson, P.S. Haffner, M.C. Plymate, S.R. de Bono, J.S. Sharp, A. (2022). Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer. , Vol.28 (16), pp. 3509-3525.  show abstract

Fenor de la Maza, M.D. Chandran, K. Rekowski, J. Shui, I.M. Gurel, B. Cross, E. Carreira, S. Yuan, W. Westaby, D. Miranda, S. Ferreira, A. Seed, G. Crespo, M. Figueiredo, I. Bertan, C. Gil, V. Riisnaes, R. Sharp, A. Rodrigues, D.N. Rescigno, P. Tunariu, N. Liu, X.Q. Cristescu, R. Schloss, C. Yap, C. de Bono, J.S. (2022). Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer. , , pp. S2588-9311(22)00060.  show abstract

Sowalsky, A.G. Sharp, A. Trostel, S.Y. de Bono, J.S. Plymate, S.R. (2021). AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification. , Vol.28, pp. 100218-100218.

Rescigno, P. Gurel, B. Pereira, R. Crespo, M. Rekowski, J. Rediti, M. Barrero, M. Mateo, J. Bianchini, D. Messina, C. Fenor de la Maza, M.D. Chandran, K. Carmichael, J. Guo, C. Paschalis, A. Sharp, A. Seed, G. Figueiredo, I. Lambros, M. Miranda, S. Ferreira, A. Bertan, C. Riisnaes, R. Porta, N. Yuan, W. Carreira, S. de Bono, J.S. (2021). Characterizing CDK12-Mutated Prostate Cancers. Clinical cancer research : an official journal of the american association for cancer research, Vol.27 (2), pp. 566-574.  show abstract

Liang, Y. Jeganathan, S. Marastoni, S. Sharp, A. Figueiredo, I. Marcellus, R. Mawson, A. Shalev, Z. Pesic, A. Sweet, J. Guo, H. Uehling, D. Gurel, B. Neeb, A. He, H.H. Montgomery, B. Koritzinsky, M. Oakes, S. de Bono, J.S. Gleave, M. Zoubeidi, A. Wouters, B.G. Joshua, A.M. (2021). Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies. Clinical cancer research : an official journal of the american association for cancer research, .  show abstract

Westaby, D. Viscuse, P.V. Ravilla, R. de la Maza, M.D. Hahn, A. Sharp, A. de Bono, J. Aparicio, A. Fleming, M.T. (2021). Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer. American society of clinical oncology educational book, (41), pp. e190-e202.  show abstract

Welti, J. Sharp, A. Brooks, N. Yuan, W. McNair, C. Chand, S.N. Pal, A. Figueiredo, I. Riisnaes, R. Gurel, B. Rekowski, J. Bogdan, D. West, W. Young, B. Raja, M. Prosser, A. Lane, J. Thomson, S. Worthington, J. Onions, S. Shannon, J. Paoletta, S. Brown, R. Smyth, D. Harbottle, G.W. Gil, V.S. Miranda, S. Crespo, M. Ferreira, A. Pereira, R. Tunariu, N. Carreira, S. Neeb, A.J. Ning, J. Swain, A. Taddei, D. International Dream Team, S.U. Schiewer, M.J. Knudsen, K.E. Pegg, N. de Bono, J.S. (2021). Targeting p300/CBP axis in lethal prostate cancer. Cancer discovery, .  show abstract

Lozano, R. Lorente, D. Aragon, I.M. Romero-Laorden, N. Nombela, P. Mateo, J. Reid, A.H. Cendón, Y. Bianchini, D. Llacer, C. Sandhu, S.K. Sharp, A. Rescigno, P. Garcés, T. Pacheco, M.I. Flohr, P. Massard, C. López-Casas, P.P. Castro, E. de Bono, J.S. Olmos, D. (2021). Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients. Cancers, Vol.13 (10).  show abstract

Paschalis, A. Welti, J. Neeb, A.J. Yuan, W. Figueiredo, I. Pereira, R. Ferreira, A. Riisnaes, R. Rodrigues, D.N. Jimenez-Vacas, J.M. Kim, S. Uo, T. Di Micco, P. Tumber, A. Islam, M.S. Moesser, M.A. Abboud, M. Kawamura, A. Gurel, B. Christova, R. Gil, V.S. Buroni, L. Crespo, M. Miranda, S. Lambros, M.B. Carreira, S. Tunariu, N. Alimonti, A. Al-Lazikani, B. Schofield, C.J. Plymate, S.R. Sharp, A. de Bono, J.S. (2021). JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. Cancer research, Vol.81 (4), pp. 1087-1100 (14).

Westaby, D. Jimenez-Vacas, J.M. Padilha, A. Varkaris, A. Balk, S.P. de Bono, J.S. Sharp, A. (2021). Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer. Cancers, Vol.14 (1).  show abstract

Miyahira, A.K. Sharp, A. Ellis, L. Jones, J. Kaochar, S. Larman, H.B. Quigley, D.A. Ye, H. Simons, J.W. Pienta, K.J. Soule, H.R. (2020). Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting. The prostate, Vol.80 (2), pp. 113-132.

Alajati, A. D'Ambrosio, M. Troiani, M. Mosole, S. Pellegrini, L. Chen, J. Revandkar, A. Bolis, M. Theurillat, J.-. Guccini, I. Losa, M. Calcinotto, A. De Bernardis, G. Pasquini, E. D'Antuono, R. Sharp, A. Figueiredo, I. Nava Rodrigues, D. Welti, J. Gil, V. Yuan, W. Vlajnic, T. Bubendorf, L. Chiorino, G. Gnetti, L. Torrano, V. Carracedo, A. Camplese, L. Hirabayashi, S. Canato, E. Pasut, G. Montopoli, M. Rüschoff, J.H. Wild, P. Moch, H. De Bono, J. Alimonti, A. (2020). CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. The journal of clinical investigation, Vol.130 (5), pp. 2435-2450.  show abstract

Kolinsky, M.P. Rescigno, P. Bianchini, D. Zafeiriou, Z. Mehra, N. Mateo, J. Michalarea, V. Riisnaes, R. Crespo, M. Figueiredo, I. Miranda, S. Nava Rodrigues, D. Flohr, P. Tunariu, N. Banerji, U. Ruddle, R. Sharp, A. Welti, J. Lambros, M. Carreira, S. Raynaud, F.I. Swales, K.E. Plymate, S. Luo, J. Tovey, H. Porta, N. Slade, R. Leonard, L. Hall, E. de Bono, J.S. (2020). A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer. Annals of oncology : official journal of the european society for medical oncology, Vol.31 (5), pp. 619-625.  show abstract

Neeb, A. Herranz, N. Arce-Gallego, S. Miranda, S. Buroni, L. Yuan, W. Athie, A. Casals, T. Carmichael, J. Rodrigues, D.N. Gurel, B. Rescigno, P. Rekowski, J. Welti, J. Riisnaes, R. Gil, V. Ning, J. Wagner, V. Casanova-Salas, I. Cordoba, S. Castro, N. Fenor de la Maza, M.D. Seed, G. Chandran, K. Ferreira, A. Figueiredo, I. Bertan, C. Bianchini, D. Aversa, C. Paschalis, A. Gonzalez, M. Morales-Barrera, R. Suarez, C. Carles, J. Swain, A. Sharp, A. Gil, J. Serra, V. Lord, C. Carreira, S. Mateo, J. de Bono, J.S. (2020). Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors. European urology, .  show abstract

Ramanand, S.G. Chen, Y. Yuan, J. Daescu, K. Lambros, M.B. Houlahan, K.E. Carreira, S. Yuan, W. Baek, G. Sharp, A. Paschalis, A. Kanchwala, M. Gao, Y. Aslam, A. Safdar, N. Zhan, X. Raj, G.V. Xing, C. Boutros, P.C. de Bono, J. Zhang, M.Q. Mani, R.S. (2020). The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer. The journal of clinical investigation, Vol.130 (8), pp. 3987-4005.  show abstract

Lu, C. Terbuch, A. Dolling, D. Yu, J. Wang, H. Chen, Y. Fountain, J. Bertan, C. Sharp, A. Carreira, S. Isaacs, W.B. Antonarakis, E.S. De Bono, J.S. Luo, J. (2020). Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c 1245C genotype. Annals of oncology, Vol.31 (9), pp. 1178-1185.

Nava Rodrigues, D. Casiraghi, N. Romanel, A. Crespo, M. Miranda, S. Rescigno, P. Figueiredo, I. Riisnaes, R. Carreira, S. Sumanasuriya, S. Gasperini, P. Sharp, A. Mateo, J. Makay, A. McNair, C. Schiewer, M. Knudsen, K. Boysen, G. Demichelis, F. de Bono, J.S. (2019). RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (2), pp. 687-697.  show abstract

Sharp, A. Coleman, I. Yuan, W. Sprenger, C. Dolling, D. Rodrigues, D.N. Russo, J.W. Figueiredo, I. Bertan, C. Seed, G. Riisnaes, R. Uo, T. Neeb, A. Welti, J. Morrissey, C. Carreira, S. Luo, J. Nelson, P.S. Balk, S.P. True, L.D. de Bono, J.S. Plymate, S.R. (2019). Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. The journal of clinical investigation, Vol.129 (1), pp. 192-208.  show abstract

Zafeiriou, Z. Bianchini, D. Chandler, R. Rescigno, P. Yuan, W. Carreira, S. Barrero, M. Petremolo, A. Miranda, S. Riisnaes, R. Rodrigues, D.N. Gurel, B. Sumanasuriya, S. Paschalis, A. Sharp, A. Mateo, J. Tunariu, N. Chinnaiyan, A.M. Pritchard, C.C. Kelly, K. de Bono, J.S. (2019). Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency. European urology, Vol.75 (1), pp. 184-192.  show abstract

Li, S. Fong, K.-. Gritsina, G. Zhang, A. Zhao, J.C. Kim, J. Sharp, A. Yuan, W. Aversa, C. Yang, X.J. Nelson, P.S. Feng, F.Y. Chinnaiyan, A.M. de Bono, J.S. Morrissey, C. Rettig, M.B. Yu, J. (2019). Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer research, Vol.79 (10), pp. 2580-2592.  show abstract

Fletcher, C.E. Sulpice, E. Combe, S. Shibakawa, A. Leach, D.A. Hamilton, M.P. Chrysostomou, S.L. Sharp, A. Welti, J. Yuan, W. Dart, D.A. Knight, E. Ning, J. Francis, J.C. Kounatidou, E.E. Gaughan, L. Swain, A. Lupold, S.E. de Bono, J.S. McGuire, S.E. Gidrol, X. Bevan, C.L. (2019). Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene, Vol.38 (28), pp. 5700-5724.  show abstract

Paschalis, A. Sheehan, B. Riisnaes, R. Rodrigues, D.N. Gurel, B. Bertan, C. Ferreira, A. Lambros, M.B. Seed, G. Yuan, W. Dolling, D. Welti, J.C. Neeb, A. Sumanasuriya, S. Rescigno, P. Bianchini, D. Tunariu, N. Carreira, S. Sharp, A. Oyen, W. de Bono, J.S. (2019). Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer. European urology, Vol.76 (4), pp. 469-478.  show abstract

Sharp, A. Welti, J.C. Lambros, M.B. Dolling, D. Rodrigues, D.N. Pope, L. Aversa, C. Figueiredo, I. Fraser, J. Ahmad, Z. Lu, C. Rescigno, P. Kolinsky, M. Bertan, C. Seed, G. Riisnaes, R. Miranda, S. Crespo, M. Pereira, R. Ferreira, A. Fowler, G. Ebbs, B. Flohr, P. Neeb, A. Bianchini, D. Petremolo, A. Sumanasuriya, S. Paschalis, A. Mateo, J. Tunariu, N. Yuan, W. Carreira, S. Plymate, S.R. Luo, J. de Bono, J.S. (2019). Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer. European urology, Vol.76 (5), pp. 676-685.  show abstract

Plymate, S.R. Sharp, A. de Bono, J.S. (2018). Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer. Jama oncology, Vol.4 (9), pp. 1187-1187.

Li, X. Baek, G. Ramanand, S.G. Sharp, A. Gao, Y. Yuan, W. Welti, J. Rodrigues, D.N. Dolling, D. Figueiredo, I. Sumanasuriya, S. Crespo, M. Aslam, A. Li, R. Yin, Y. Mukherjee, B. Kanchwala, M. Hughes, A.M. Halsey, W.S. Chiang, C.-. Xing, C. Raj, G.V. Burma, S. de Bono, J. Mani, R.S. (2018). BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. Cell reports, Vol.22 (3), pp. 796-808.  show abstract

Rescigno, P. Lorente, D. Dolling, D. Ferraldeschi, R. Rodrigues, D.N. Riisnaes, R. Miranda, S. Bianchini, D. Zafeiriou, Z. Sideris, S. Ferreira, A. Figueiredo, I. Sumanasuriya, S. Mateo, J. Perez-Lopez, R. Sharp, A. Tunariu, N. de Bono, J.S. (2018). Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. European urology oncology, Vol.1 (1), pp. 71-77.  show abstract

Zhu, Y. Sharp, A. Anderson, C.M. Silberstein, J.L. Taylor, M. Lu, C. Zhao, P. De Marzo, A.M. Antonarakis, E.S. Wang, M. Wu, X. Luo, Y. Su, N. Nava Rodrigues, D. Figueiredo, I. Welti, J. Park, E. Ma, X.-. Coleman, I. Morrissey, C. Plymate, S.R. Nelson, P.S. de Bono, J.S. Luo, J. (2018). Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. European urology, Vol.73 (5), pp. 727-735.

Calcinotto, A. Spataro, C. Zagato, E. Di Mitri, D. Gil, V. Crespo, M. De Bernardis, G. Losa, M. Mirenda, M. Pasquini, E. Rinaldi, A. Sumanasuriya, S. Lambros, M.B. Neeb, A. Lucianò, R. Bravi, C.A. Nava-Rodrigues, D. Dolling, D. Prayer-Galetti, T. Ferreira, A. Briganti, A. Esposito, A. Barry, S. Yuan, W. Sharp, A. de Bono, J. Alimonti, A. (2018). IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature, Vol.559 (7714), pp. 363-369.  show abstract

Welti, J. Sharp, A. Yuan, W. Dolling, D. Nava Rodrigues, D. Figueiredo, I. Gil, V. Neeb, A. Clarke, M. Seed, G. Crespo, M. Sumanasuriya, S. Ning, J. Knight, E. Francis, J.C. Hughes, A. Halsey, W.S. Paschalis, A. Mani, R.S. Raj, G.V. Plymate, S.R. Carreira, S. Boysen, G. Chinnaiyan, A.M. Swain, A. de Bono, J.S. International SU2C/PCF Prostate Cancer Dream Team, (2018). Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC). Clinical cancer research : an official journal of the american association for cancer research, Vol.24 (13), pp. 3149-3162.  show abstract

Nava Rodrigues, D. Rescigno, P. Liu, D. Yuan, W. Carreira, S. Lambros, M.B. Seed, G. Mateo, J. Riisnaes, R. Mullane, S. Margolis, C. Miao, D. Miranda, S. Dolling, D. Clarke, M. Bertan, C. Crespo, M. Boysen, G. Ferreira, A. Sharp, A. Figueiredo, I. Keliher, D. Aldubayan, S. Burke, K.P. Sumanasuriya, S. Fontes, M.S. Bianchini, D. Zafeiriou, Z. Teixeira Mendes, L.S. Mouw, K. Schweizer, M.T. Pritchard, C.C. Salipante, S. Taplin, M.-. Beltran, H. Rubin, M.A. Cieslik, M. Robinson, D. Heath, E. Schultz, N. Armenia, J. Abida, W. Scher, H. Lord, C. D'Andrea, A. Sawyers, C.L. Chinnaiyan, A.M. Alimonti, A. Nelson, P.S. Drake, C.G. Van Allen, E.M. de Bono, J.S. (2018). Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer. The journal of clinical investigation, Vol.128 (10), pp. 4441-4453.  show abstract

Paschalis, A. Sharp, A. Welti, J.C. Neeb, A. Raj, G.V. Luo, J. Plymate, S.R. de Bono, J.S. (2018). Alternative splicing in prostate cancer. Nature reviews. clinical oncology, Vol.15 (11), pp. 663-675.  show abstract

Boysen, G. Rodrigues, D.N. Rescigno, P. Seed, G. Dolling, D. Riisnaes, R. Crespo, M. Zafeiriou, Z. Sumanasuriya, S. Bianchini, D. Hunt, J. Moloney, D. Perez-Lopez, R. Tunariu, N. Miranda, S. Figueiredo, I. Ferreira, A. Christova, R. Gil, V. Aziz, S. Bertan, C. de Oliveira, F.M. Atkin, M. Clarke, M. Goodall, J. Sharp, A. MacDonald, T. Rubin, M.A. Yuan, W. Barbieri, C.E. Carreira, S. Mateo, J. de Bono, J.S. (2018). SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity. Clinical cancer research : an official journal of the american association for cancer research, Vol.24 (22), pp. 5585-5593.  show abstract

Lambros, M.B. Seed, G. Sumanasuriya, S. Gil, V. Crespo, M. Fontes, M. Chandler, R. Mehra, N. Fowler, G. Ebbs, B. Flohr, P. Miranda, S. Yuan, W. Mackay, A. Ferreira, A. Pereira, R. Bertan, C. Figueiredo, I. Riisnaes, R. Rodrigues, D.N. Sharp, A. Goodall, J. Boysen, G. Carreira, S. Bianchini, D. Rescigno, P. Zafeiriou, Z. Hunt, J. Moloney, D. Hamilton, L. Neves, R.P. Swennenhuis, J. Andree, K. Stoecklein, N.H. Terstappen, L.W. de Bono, J.S. (2018). Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis. Clinical cancer research : an official journal of the american association for cancer research, Vol.24 (22), pp. 5635-5644.  show abstract

Mateo, J. Sharp, A. de Bono, J.S. (2017). Investigating Genomic Aberrations of the Androgen Receptor: Moving Closer to More Precise Prostate Cancer Care?. European urology, Vol.72 (2), pp. 201-204.

Goodall, J. Mateo, J. Yuan, W. Mossop, H. Porta, N. Miranda, S. Perez-Lopez, R. Dolling, D. Robinson, D.R. Sandhu, S. Fowler, G. Ebbs, B. Flohr, P. Seed, G. Rodrigues, D.N. Boysen, G. Bertan, C. Atkin, M. Clarke, M. Crespo, M. Figueiredo, I. Riisnaes, R. Sumanasuriya, S. Rescigno, P. Zafeiriou, Z. Sharp, A. Tunariu, N. Bianchini, D. Gillman, A. Lord, C.J. Hall, E. Chinnaiyan, A.M. Carreira, S. de Bono, J.S. TOPARP-A investigators, (2017). Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. Cancer discovery, Vol.7 (9), pp. 1006-1017.  show abstract

Cato, L. Neeb, A. Sharp, A. Buzón, V. Ficarro, S.B. Yang, L. Muhle-Goll, C. Kuznik, N.C. Riisnaes, R. Nava Rodrigues, D. Armant, O. Gourain, V. Adelmant, G. Ntim, E.A. Westerling, T. Dolling, D. Rescigno, P. Figueiredo, I. Fauser, F. Wu, J. Rottenberg, J.T. Shatkina, L. Ester, C. Luy, B. Puchta, H. Troppmair, J. Jung, N. Bräse, S. Strähle, U. Marto, J.A. Nienhaus, G.U. Al-Lazikani, B. Salvatella, X. de Bono, J.S. Cato, A.C. Brown, M. (2017). Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. Elife, Vol.6.  show abstract

Mehra, N. Sharp, A. Lorente, D. Dolling, D. Sumanasuriya, S. Johnson, B. Dearnaley, D. Parker, C. de Bono, J. (2017). Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids. Clinical genitourinary cancer, Vol.15 (6), pp. 678-684.e1.  show abstract

Kumar, R. Lu, S.K. Minchom, A. Sharp, A. Davidson, M. Gunapala, R. Yap, T.A. Bhosle, J. Popat, S. O’Brien, M.E. (2016). A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer chemotherapy and pharmacology, Vol.77 (2), pp. 375-383.

Zafeiriou, Z. Jayaram, A. Sharp, A. de Bono, J.S. (2016). Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents. Drugs, Vol.76 (4), pp. 421-430.

Redana, S. Sharp, A. Papadimitraki, E. Lote, H. Capelan, M. Ring, A. (2016). Rates of Venous Thromboembolism (VTE) and Other Major Complications During Peri-operative Chemotherapy (CT) for Early Breast Cancer (EBC) in an Off-study Population. Clinical oncology, Vol.28 (5), pp. e7-e7.

Sharp, A. Bhosle, J. Abdelraouf, F. Popat, S. O'Brien, M. Yap, T.A. (2016). Development of molecularly targeted agents and immunotherapies in small cell lung cancer. European journal of cancer (oxford, england : 1990), Vol.60, pp. 26-39.  show abstract

Sharp, A. Welti, J. Blagg, J. de Bono, J.S. (2016). Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the american association for cancer research, Vol.22 (17), pp. 4280-4282.  show abstract

Lote, H. Sharp, A. Redana, S. Papadimitraki, E. Capelan, M. Ring, A. (2016). Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer. Clinical oncology, Vol.28 (9), pp. 597-603.

Welti, J. Rodrigues, D.N. Sharp, A. Sun, S. Lorente, D. Riisnaes, R. Figueiredo, I. Zafeiriou, Z. Rescigno, P. de Bono, J.S. Plymate, S.R. (2016). Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer. European urology, Vol.70 (4), pp. 599-608.  show abstract

Redana, S. Sharp, A. Lote, H. Mohammed, K. Papadimitraki, E. Capelan, M. Ring, A. (2016). Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. The breast, Vol.30, pp. 13-18.

Abdelraouf, F. Sharp, A. Maurya, M. Mair, D. Wotherspoon, A. Leary, A. Gonzalez de Castro, D. Bhosle, J. Nassef, A. Gaafar, T. Popat, S. Yap, T.A. O’Brien, M. (2015). Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice. Bmc research notes, Vol.8 (1).

Douglas, J. Sharp, A. Chau, C. Head, J. Drake, T. Wheater, M. Geldart, T. Mead, G. Crabb, S.J. (2014). Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract. British journal of cancer, Vol.110 (7), pp. 1759-1766.

Sharp, A. Cutress, R.I. Johnson, P.W. Packham, G. Townsend, P.A. (2009). Short peptides derived from the BAG-1 C-terminus inhibit the interaction between BAG-1 and HSC70 and decrease breast cancer cell growth. Febs letters, Vol.583 (21), pp. 3405-3411.

Sharp, A. Crabb, S.J. Johnson, P.W. Hague, A. Cutress, R. Townsend, P.A. Ganesan, A. Packham, G. (2009). Thioflavin S (NSC71948) Interferes with Bcl-2-Associated Athanogene (BAG-1)-Mediated Protein-Protein Interactions. Journal of pharmacology and experimental therapeutics, Vol.331 (2), pp. 680-689.

Barnes, J.D. Arhel, N.J. Lee, S.S. Sharp, A. Al-Okail, M. Packham, G. Hague, A. Paraskeva, C. Williams, A.C. (2005). Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis, Vol.10 (2), pp. 301-311.

Sharp, A. Crabb, S.J. Cutress, R.I. Brimmell, M. Wang, X.-. Packham, G. Townsend, P.A. (2004). BAG-1 in carcinogenesis. Expert reviews in molecular medicine, Vol.6 (7), pp. 1-15.  show abstract

Arhel, N.J. Packham, G. Townsend, P.A. Collard, T.J. H-Zadeh, A.M. Sharp, A. Cutress, R.I. Malik, K. Hague, A. Paraskeva, C. Williams, A.C. (2003). The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines. International journal of cancer, Vol.106 (3), pp. 364-371.

Townsend, P.A. Cutress, R.I. Sharp, A. Brimmell, M. Packham, G. (2003). BAG-1: a multifunctional regulator of cell growth and survival. Biochimica et biophysica acta (bba) - reviews on cancer, Vol.1603 (2), pp. 83-98.

Cutress, R.I. Townsend, P.A. Sharp, A. Maison, A. Wood, L. Lee, R. Brimmell, M. Mullee, M.A. Johnson, P.W. Royle, G.T. Bateman, A.C. Packham, G. (2003). The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene, Vol.22 (32), pp. 4973-4982.

Townsend, P.A. Cutress, R.I. Sharp, A. Brimmell, M. Packham, G. (2003). BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway. Cancer research, Vol.63 (14), pp. 4150-4157.

Sharp, A. Johnston, S.R. Dose-Reduced Trastuzumab Emtansine: Active and Safe in Acute Hepatic Dysfunction. Case reports in oncology, Vol.8 (1), pp. 113-121.  show abstract

Gil, V. Miranda, S. Riisnaes, R. Gurel, B. D'Ambrosio, M. Vasciaveo, A. Crespo, M. Ferreira, A. Brina, D. Troiani, M. Sharp, A. Sheehan, B. Christova, R. Seed, G. Figueiredo, I. Lambros, M. Dolling, D. Rekowski, J. Alajati, A. Clarke, M. Pereira, R. Flohr, P. Fowler, G. Boysen, G. Sumanasuriya, S. Bianchini, D. Rescigno, P. Aversa, C. Tunariu, N. Guo, C. Paschalis, A. Bertan, C. Buroni, L. Ning, J. Carreira, S. Workman, P. Swain, A. Califano, A. Shen, M.M. Alimonti, A. Neeb, A. Welti, J. Yuan, W. de Bono, J. PCF/SU2C International Prostate Cancer Dream Team, HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer research, Vol.81 (24), pp. 6207-6218.  show abstract

Sumanasuriya, S. Seed, G. Parr, H. Christova, R. Pope, L. Bertan, C. Bianchini, D. Rescigno, P. Figueiredo, I. Goodall, J. Fowler, G. Flohr, P. Mehra, N. Neeb, A. Rekowski, J. Eisenberger, M. Sartor, O. Oudard, S. Geffriaud-Ricouard, C. Ozatilgan, A. Chadjaa, M. Macé, S. Lord, C. Baxter, J. Pettitt, S. Lambros, M. Sharp, A. Mateo, J. Carreira, S. Yuan, W. de Bono, J.S. Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA. European urology, Vol.80 (2), pp. 243-253.  show abstract

Guo, C. Crespo, M. Gurel, B. Dolling, D. Rekowski, J. Sharp, A. Petremolo, A. Sumanasuriya, S. Rodrigues, D.N. Ferreira, A. Pereira, R. Figueiredo, I. Mehra, N. Lambros, M.B. Neeb, A. Gil, V. Seed, G. Terstappen, L. Alimonti, A. Drake, C.G. Yuan, W. de Bono, J.S. International SU2C PCF Prostate Cancer Dream Team, CD38 in Advanced Prostate Cancers. European urology, .  show abstract


Patents and patent applications

Paschalis, A.Sheehan, B.Riisnaes, R.Nava Rodrigues, D.Gurel, B.Bertan, C.Ferreira, A.Lambros, M.B.Seed, G.Yuan, W.Dolling, D.Welti, J.Neeb, A.Sumanasuriya, S.Rescigno, P.Bianchini, D.Tunariu, N.Carreira, S.Sharp, A.De Bono, J.S. (2019). PSMA heterogeneity and DNA repair defects in prostate cancer..